Next Article in Journal
Ascending Aortic Aneurysms: From Pathophysiology to Surgical Repair
Previous Article in Journal
The Accessible Vascular Indicators for Mild Cognitive Impairment Detection: The Predictive Value of the Ankle-Brachial Index
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients

by
Martino Belvederi Murri
1,2,
Angela Muscettola
1,*,
Michele Specchia
2,
Chiara Montemitro
1,2,
Luigi Zerbinati
1,2,
Marco Cruciata
1,
Tommaso Toffanin
1,2,
Guido Sciavicco
3,
Rosangela Caruso
1,2,
Federica Sancassiani
4,
Mauro Giovanni Carta
4,
Luigi Grassi
1,2 and
Maria Giulia Nanni
1,2
1
Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy
2
Integrated Department of Mental Health and Pathological Addictions, Local Health Trust of Ferrara, 44124 Ferrara, Italy
3
Department of Mathematics and Computer Science, University of Ferrara, 44121 Ferrara, Italy
4
Department of Medical Sciences and Public Health, University of Cagliari IT, 09124 Cagliari, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(19), 6992; https://doi.org/10.3390/jcm14196992
Submission received: 11 September 2025 / Revised: 23 September 2025 / Accepted: 28 September 2025 / Published: 2 October 2025
(This article belongs to the Section Mental Health)

Abstract

Background: Demoralization, anxiety, irritability, and depression are common among hospital patients and are associated with poorer outcomes and greater healthcare burden. Early identification is essential, but simultaneous screening across multiple domains is often impractical with questionnaires. Computerized Adaptive Testing (CAT) offers a solution by tailoring item administration, reducing test length while preserving measurement precision. The aim of this study was to develop and validate FRIDA (Four-factor Rapid Interactive Diagnostic Assessment), a freely accessible, web-based CAT for rapid multidimensional screening of psychopathology in hospital patients. Methods: We analysed data from 472 medically ill in-patients at a University Hospital. Item calibration was performed using a four-factor graded response model (demoralization, anxiety, irritability, depression) in the mirt package. CAT simulations were run with 1000 virtual respondents to optimize item selection, exposure control, and stopping rules. The best configuration was applied to the real dataset. Criterion validity for demoralization was evaluated against the Diagnostic Criteria for Psychosomatic Research (DCPR). Results: The four-factor model showed good fit (CFI = 0.947, RMSEA = 0.080). Factor correlations were moderate to high, with the strongest overlap between demoralization and depression (r = 0.93). In simulations, the CAT required, on average, 7.8 items and recovered trait estimates with high accuracy (r = 0.94–0.97). In real patients, mean test length was 11 items, with accuracy of r = 0.95 across domains. FRIDA demonstrated good criterion validity for demoralization (AUC = 0.816; sensitivity 80%, specificity 67.5%). Conclusions: FRIDA is the first freely available, multidimensional CAT for rapid screening of psychopathology in hospital patients. It offers a scalable, efficient, and precise tool for integrating mental health assessment into routine hospital care.

1. Introduction

The Computerized Adaptive Test (CAT) may be particularly useful for the setting of Consultation Liaison Psychiatry (CLP), possibly contributing to early identification and management of psychopathology.
Demoralization, anxiety, irritability, and depression are among the most common and disabling dimensions of psychopathology in hospital patients. Prevalence estimates suggest that between a third and one-half of in-patients experience clinically significant symptoms [1,2,3,4,5]. These domains are not independent but highly interrelated—recent views support the possibility that the symptoms may interact and promote reciprocally [6,7,8]. While anxiety and depression primarily reflect mood-related symptoms, demoralization has been conceptualized as a syndrome of loss of meaning, subjective incompetence, and motivational impairment [9]. Despite these differences, these constructs frequently co-occur in hospital patients, show strong empirical correlations, and exert reciprocal influences. Assessing them jointly within a multidimensional framework, therefore, allows for capturing both shared and distinct aspects of emotional distress, providing a more comprehensive and clinically informative evaluation. For instance, demoralization may precede or accompany depressive episodes, yet it can also precede it as a distinct syndrome, particularly in the context of medical illness [1,9,10]. Anxiety and depression frequently co-occur, with comorbidity rates exceeding 50%, complicating both diagnosis and treatment [11]. Hostility and irritability are extremely common but less frequently studied [2,12,13]. These psychopathological domains have great clinical salience, both for individual suffering and clinical course: they have been associated with negative outcomes, such as prolonged hospital stays, heightened distress, impaired communication with staff, and reduced quality of life during hospitalization [1,2,14,15]. Other possible consequences of psychopathology include reduced adherence to treatments, increased complications, longer hospital stays, greater risk of readmission or mortality.
Identification of these conditions is important [16], especially considering that the effectiveness of CLP interventions managing them is well established [17]. Screening procedures have been discussed, particularly considering that the majority of patients suffering from such disorders remain undetected and do not remit spontaneously [16,18,19]. This implies a risk of avoidable suffering, impairing medical recovery and even suicidal behaviour within or outside the hospital [20,21]. The implications of screening procedures, however, should not be over-emphasized: for instance, a case has been made on the length and burden of such procedures, especially when multiple dimensions need to be considered simultaneously [22]. Traditional questionnaires may, in fact, require multiple scales or large item sets, reducing feasibility in hospital workflows. Moreover, the interpretation of scores and transmission of results to clinicians may further increase the overall burden, ultimately undermining their utility for decision making at the bedside.
CAT addresses these limitations. By applying Item Response Theory (IRT), CAT tailors item administration to the individual, reducing test length while maintaining or even improving measurement precision. This strategy consistently enhances patient experience, decreases response burden, and provides more accurate estimates compared with fixed-item questionnaires [23,24,25].
Most applications of CAT in psychiatry have focused on unidimensional constructs such as depression or anxiety, often derived from PROMIS or PHQ frameworks [26,27]. Work on multidimensional symptom systems exists but was often conducted within single disorders (e.g., substance use in [25] or outside hospital populations [28]). The CAT-MH system developed by Gibbons and colleagues integrates several domains (depression, anxiety, PTSD, ADHD, suicidality) through multidimensional item response models, but it is proprietary and not freely available [24]. Compared with CAT-MH, FRIDA was specifically designed for hospital patients and focuses on four domains that are highly prevalent in this setting: demoralization, depression, anxiety, and irritability. The inclusion of demoralization and irritability represents a novel contribution, as these constructs are not routinely covered by existing adaptive systems. Furthermore, FRIDA is fully open access, allowing free clinical and research use.
Our group previously conducted IRT studies of demoralization, although we did not develop a CAT [9,14]. The aim of this study was, therefore, to develop and test FRIDA (Four-factor Rapid Interactive Diagnostic Assessment): a freely accessible, web-based CAT designed for the rapid multidimensional screening of demoralization, anxiety, irritability, and depression in general hospital patients.

2. Materials and Methods

2.1. Participants

This study uses data from a previous study on demoralization in hospitalized individuals [14]. Medically ill patients were recruited between 2018 and 2020 from the Sant’Anna University Hospital in Ferrara, Italy, using a convenience sampling strategy. Participation was offered to in-patients recruited from a range of medical wards—internal medicine, cardiology, endocrinology, nephrology, gastroenterology, pneumology, rheumatology, and oncology. Inclusion criteria were as follows: (1) age ≥ 18 years; (2) capacity to engage in a clinical interview; (3) absence of delirium or other cognitive impairment; and (4) fluency in Italian. After receiving a full explanation of the study, all participants provided written informed consent; no financial or material compensation was offered. Of the approximately 646 patients invited, 472 agreed to participate (response rate 73%). A trained research assistant then conducted a one-to-one session consisting of a semi-structured interview and a battery of psychometric questionnaires; the session lasted approximately 60 min. The study was approved by the Ethical Committee of the Emilia-Romagna Region, “Central Emilia” area (CE-AVEC).

2.2. Measures

Demoralization. Demoralization was quantified in two ways. First, patients completed the twenty-four-item Demoralization Scale (DS-24) [14,29], which asks respondents to indicate how often in the previous fortnight they have experienced feelings such as discouragement, loss of meaning or a sense of personal failure, on a five-point scale ranging from 0 (“never”) to 4 (“all the time”).
The interview-based reference we used was the Demoralization module of the Diagnostic Criteria for Psychosomatic Research (DCPR/D) [30,31,32]. The DCPR diagnoses demoralization when, for at least one month, the patient perceives a failure to meet important expectations, feels unable to cope with pressing problems and reports persistent hopelessness or helplessness [33]. Trained psychologists applied the module during the same session as the questionnaires. In our previous study, the DS-24 showed a clear ability to distinguish clinically defined cases of demoralization from non-cases, with an area under the ROC curve of 0.82 compared with the reference diagnostic interview [14]. Internal consistency in the present series was α = 0.94 (0.93–0.95).
Anxiety. To assess symptoms of anxiety, we used the six-item Anxiety subscale of the Brief Symptom Inventory-18 (BSI-18) [34], which asks respondents to rate how much they have been bothered by each symptom in the past seven days on a five-point Likert scale (0 = Not at all to 4 = Extremely). Internal consistency in the present series was α = 0.85 (0.83–0.87).
Irritability and hostility. To assess irritability and hostility, we selected a set of exploratory items from the BSI-53 based on prior evidence linking these symptoms to demoralization, anxious preoccupation, impaired quality of life, interpersonal conflict, and difficulties in emotional expression (2). These items were included as candidate indicators for a distinct irritability dimension in subsequent dimensional and adaptive modelling. Internal consistency in the present series was α = 0.82 (0.79–0.84).
Depressive symptoms. Depression was assessed with the Italian version [35] of the Patient Health Questionnaire-9 (PHQ-9) [36]. Respondents indicate the frequency of nine DSM-IV depressive symptoms over the previous two weeks on a four-point scale from 0 (“not at all”) to 3 (“nearly every day”). In the wider literature, total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively. Internal consistency in the present series was α = 0.83 (0.81–0.85).
All instruments were administered using validated Italian versions, ensuring linguistic and cultural appropriateness for the study population.

2.3. Statistical Analysis

We used methods based on the Item Response Theory (IRT). IRT allows one to model the non-linear relationship between item responses and underlying latent traits, and provides item-level information such as thresholds and discrimination parameters [37,38].
Item calibration was performed using a multidimensional graded response model (GRM) implemented in the mirt R package (version 1.14.3.) [37]. First, we tested separate models for each bank, extracting item information functions. A four-factor structure—reflecting demoralization, anxiety, irritability, and depression—was then adopted, based on theoretical considerations and interpretability. The four-factor graded response model was estimated using full-information item factor analysis with the QMCEM algorithm (5000 quasi–Monte Carlo points, Ramsay acceleration, BFGS M-step optimizer). We checked the IRT model assumption of local independence by inspecting the residual correlation matrix and Q3 statistics with quasi-Monte Carlo integration.
We developed the CAT engine using the mirtCAT R package [39], based on the four-factor model. First, we assessed efficiency and accuracy by conducting simulations with 1000 virtual respondents, whose data were artificially generated from the fitted model; then, we applied the best-performing configuration to the real dataset, evaluating its behaviour with the actual patient responses. In particular, we explored different combinations of starting and stopping rules, item selection criteria, and exposure controls. We tested multiple starting rules (random versus adaptive selection from high-information items) and item selection methods suitable for multidimensional models, including random, determinant-based (Drule) and Kullback–Leibler divergence (KL, KLn). Exposure control vectors were used in some conditions to prioritise well-performing and clinically relevant items identified in the calibration phase. Stopping criteria included the following: (1) lower bounds on measurement precision for each latent trait, expressed as a maximum acceptable standard error (0.35–0.50); (2) fixed minimum and maximum test lengths, initially set between 4 and 44 items, and later narrowed based on simulation performance; (3) a maximum change in ability estimates across successive items (Δθ), as an additional stability criterion.
For clinical use, we built a freely accessible custom web-based graphical interface to present instructions, collect demographic information, and administer items via radio-button responses. We planned to present users with a graphical tool to represent theta values as continuum, plus a highlighted warning when theta exceeded the value of 0, corresponding to the midpoint of the standard normal distribution of theta. For demoralization, we were also able to examine this criterion’s validity using the DCPR diagnosis of demoralization as the gold standard. Thus, we examined the sensitivity and specificity of theta = 0 using AUC-ROC analyses, hoping to maximize sensitivity and negative predictive value.

3. Results

3.1. Sample Characteristics

The sample included 472 hospitalized patients (212 M and 260 F), with a mean age of 62.9 ± 17.7 years (Supplementary Table S1). Most participants were married or cohabiting (56%) and lived with a spouse or partner (56%), while 26% lived alone. Educational attainment was generally low, with 35% having only primary school and 6.8% reporting no qualifications. The most frequent admission reasons were cardiovascular (18%), gastroenterologic (17%), and neurologic (11%) conditions, and 60% of participants were retired.

3.2. Item Response Theory Model

The four-factor model converged within 56 iterations, yielding acceptable fit indices (M2 = 3576, df = 896, RMSEA = 0.080, 90% CI = 0.077–0.082; SRMSR = 0.079; CFI = 0.947; TLI = 0.944). The standardized factor loadings indicated substantial variance accounted for by the factors, with SS loadings of 11.60, 3.70, 3.61, and 4.27 for Factors 1–4, corresponding to proportions of variance of 26.4%, 8.4%, 8.2%, and 9.7%, respectively. Factor correlations were generally moderate to high, the strongest being between Factor 1 (Demoralization) and Factor 4 (Depression; r = 0.93), followed by correlations of 0.759 between F2 (Anxiety) and F3 (Hostility). Moderate correlations were observed between F1 and F2 (0.671), F1 and F3 (0.526), and F3 and F4 (0.498).
The Item Characteristic Curves (ICCs) (Figure 1) show the expected graded response patterns for all items, with ordered category curves and smooth transitions across the latent trait continuum. Most items exhibit well-separated thresholds, suggesting adequate discrimination between adjacent response categories. A few items display category curves with limited peak probability (e.g., extreme categories used infrequently), which may reflect low endorsement rates rather than model misspecification.
Item fit statistics indicated that the majority of items demonstrated adequate fit to the model. A subset of items (e.g., demo2, demo3, demo6, demo9, demo11, demo15, demo16, demo19, demo23, bsi46, phqd) showed significant misfit at p < 0.05, though the associated RMSEA.S_X2 values were generally small (≤0.035), suggesting that misfit was modest in magnitude. These results, together with the generally high factor loadings and communalities (Supplementary Table S2), supported the adequacy of the four-factor solution in representing the observed item response patterns.
The local independence assumption was supported by residual pairwise correlations between items below 0.50, except that between phq_g and phq_c (R = 0.508), well below problematic values (≈0.60–0.70). All items were retained in the item bank.

3.3. Computerized Adaptive Testing

The CAT was developed from the four-factor model: in its final version, item selection began with demoralization item 18, followed by the determinant-based rule weighted by posterior ability estimates (DPrule) for item selection. Stopping criteria combined trait-specific precision thresholds (maximum standard errors of 0.45 for demoralisation and depression, 0.50 for anxiety and irritability), maximum change in ability estimates between successive items of 0.01 on each factor, and test length limits of 4–25 items. Greater exposure control was given to items with stronger psychometric and information properties identified during calibration.
To illustrate the adaptive procedure, Figure 2 shows the trajectory of one CAT administration in a 46-year-old male participant with prevalent hostility and anxiety symptoms. The algorithm administered six items: from the demoralization subscale (“I feel that I am unable to help myself”; “My life seems meaningless”), hostility (“I easily lose my temper”; “I feel easily irritable”), depression (“Little interest or pleasure in doing things”), and anxiety (“I feel nervous, tense, or restless”). After each response, the latent trait estimates for demoralization, anxiety, hostility, and depression are updated, and their standard errors progressively decrease. Final estimates for this case converge to θ = 0.22 (demoralization), θ = 0.93 (anxiety), θ = 1.58 (hostility), and θ = 0.12 (depression), with corresponding SEs between 0.33 and 0.43, indicating precise recovery with only six items.
We evaluated the CAT engine in simulated data with 1000 virtual respondents. Here, it required on average 7.76 items per simulated respondent (median = 6; IQR = 3; range = 4–25). The resulting distribution of administered items is shown in Figure 3a’s panel. Correlations between CAT-estimated and “true” latent trait values ranged from 0.94 to 0.97, with root mean square deviations of 0.24–0.28, indicating excellent recovery of trait estimate values and substantial test length reduction. The subsequent CAT simulation was applied to the original dataset of 441 real participants: it administered a mean of 10.95 items (median 7, IQR 10, range 4–25; Figure 3b panel). Accuracy for theta estimates from the four-factor model was very high across all factors, with correlations ranging from 0.948 to 0.953 and RMSD values between 0.269 and 0.298.

3.4. Development of the Web-Based Screening Tool

For clinical application, we implemented the CAT model into FRIDA (available at https://dk.aclai.unife.it/Frida (accessed on 08 September 2025). FRIDA is a web-based interface that provides a graphical display of estimated trait levels along a continuum, ranging from green (low risk) to red (high risk), with a visual indicator highlighting the respondent’s position. A warning signal is automatically triggered when the estimated theta exceeds the value of 0, corresponding to the upper half of the standard normal distribution. For demoralization, criterion validity was evaluated against the DCPR diagnosis as the gold standard. Using theta = 0 as the threshold, the tool demonstrated good discriminative ability (AUC = 0.816), with sensitivity of 80% and specificity of 67.5%. Negative predictive value was high (83.4%), while positive predictive value was lower (62.3%), indicating that the instrument is particularly effective at ruling out cases of demoralization (Figure 4).

4. Discussion

To our knowledge, this study is the first freely accessible, web-based CAT instrument for the rapid screening of psychopathology among hospital patients. The tool detects demoralization, anxiety, irritability, and depression—four domains in this patient population that are extremely common and debilitating.
Early identification of psychopathology in hospital patients is crucial, as timely recognition and intervention may improve outcomes and reduce morbidity. CLP has proven particularly effective when detection is early and systematic [21]. However, capturing the breadth of clinically relevant psychopathology often requires administering several instruments, each targeting a different domain [40]. This multiplied response burden may reduce feasibility in busy hospital settings, and different score computation may complicate the interpretation of results by clinicians. Adaptive Testing directly addresses these barriers by tailoring item selection to each respondent, improving patient experience, shortening test length, and maintaining high measurement precision across the severity spectrum [23,41].
This study follows and extends prior work on CAT in psychiatry and general medicine, where most applications have focused on unidimensional constructs, such as depression or anxiety, with CATs developed from PROMIS or fixed instruments [26,27]. In hospital or illness-specific settings, CATs have been successfully applied to improve the detection of targeted symptoms or domains, for example, substance use [25], negative mood in orthopaedic pain [27], or preoperative anxiety and depression [42], whereas multidimensional models have been mostly implemented in broader proprietary adaptive systems such as CAT-MH [24,43,44] or in large-scale assessments of cognition, daily activity, and mobility in older adults [28]. In contrast, FRIDA applies a multidimensional IRT framework to four correlated symptom domains—demoralization, anxiety, irritability, and depression—within a freely accessible tool designed specifically for hospital patients. CAT based on multidimensional IRT has been indicated as particularly efficient as it exploits the correlations among symptom domains, further reducing burden, preserving measurement precision while yielding separate yet interconnected estimates for complex traits, such as demoralization, anxiety, irritability, and depression [24].
The present tool addresses a practical clinical need: rapid, reliable screening in settings where patient time and attention are limited. By leveraging Item Response Theory, the system tailors administration to each respondent, presenting only the most informative items to achieve a predefined level of measurement precision. This allows for the combination of qualitative clinical insight with quantitative psychometric evidence, producing structured outputs that can be directly integrated into clinical decision making. In practice, this can facilitate early detection of distress across multiple domains, inform prioritization of interventions, and reduce assessment burden for both patients and staff.
Key strengths include the multidimensional design, which captures a broad spectrum of emotional distress; the adaptability of the CAT engine, which can be modified for different patient populations or clinical priorities; and its free, web-based availability, which enables wide dissemination. Limitations include the lack of screening of manifestations of severe mental disorders (e.g., bipolar disorder or psychoses). The reliance on an initial calibration sample from a single healthcare setting may affect generalizability and the lack of external validation against an interview-based criterion for measures other than demoralization. Another limitation is that the instruments differed in their assessment time frames (seven days for anxiety and irritability, two weeks for depression and demoralization, and one month for the DCPR diagnosis), which may have introduced some heterogeneity in symptom reporting. In addition, while the tool optimizes measurement efficiency, its performance in patients with cognitive impairment, language barriers, or very severe symptoms requires further evaluation. Moreover, the possibility of social desirability and recall bias should be acknowledged.
Future developments could address these issues by adapting the tool for specific populations, for example, through simplified language items, multilingual versions, or the possibility of proxy administration by caregivers or healthcare staff. Adaptation for patients with cognitive impairment could also draw on strategies explored in digital cognitive testing platforms [45], which emphasize usability through simplified instructions and accessibility features.

5. Conclusions

This study reports on the development of FRIDA, a freely available, multidimensional, web-based CAT for the rapid screening of the main four dimensions of psychological distress in hospital patients. The instrument offers a scalable, psychometrically robust solution for integrating mental health assessment into routine clinical workflows, with potential to improve early detection, documentation, and follow-up of psychiatric symptoms in general medical settings.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jcm14196992/s1, Table S1: Sample characteristics, Table S2: Model loadings and parameters.

Author Contributions

Conceptualization, M.B.M., L.G., R.C. and M.G.N.; data curation, M.B.M., M.S. and A.M.; formal analysis, M.B.M.; funding acquisition, M.B.M., R.C., L.G., F.S., M.G.C. and M.G.N.; investigation, M.B.M., L.G., R.C., L.Z. and M.G.N.; methodology, M.B.M., L.G., R.C., M.G.N. and G.S.; project administration, M.B.M., L.G., R.C. and M.G.N.; resources M.B.M., L.G., R.C., M.G.N., L.Z., M.C. and T.T.; software, M.B.M., M.S. and G.S.; supervision, M.B.M., L.G., R.C. and M.G.N.; validation, M.B.M., A.M. and C.M.; visualization, M.B.M. and A.M.; writing—original draft, M.B.M., A.M. and M.S.; writing—review and editing, M.B.M., L.G., R.C., G.S., C.M., F.S., M.G.C. and M.G.N. All authors will be updated at each stage of manuscript processing, including submission, revision, and revision reminder, via emails from our system or the assigned Assistant Editor. All authors have read and agreed to the published version of the manuscript.

Funding

This work is supported by a grant from #NEXTGENERATIONEU (NGEU) (Ministry of Health, National Recovery and Resilience Plan (NRRP). Project grant PNRR-MAD-2022-12375899 title: Cost-effectiveness of innovative, non-pharmacological strategies for early detection, prevention and tailored care of depressive disorders among cancer patients: Transcranial Magnetic Stimulation and Virtual Reality-based Cognitive Remediation.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the local Ethical Committee (CE: 90/2018/Oss/UniFe, 5 May 2018). All records in the Mental Health Register were anonymized.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The source code for FRIDA can be obtained from the corresponding author upon reasonable request for academic purposes. Due to clinical data protection policies, the dataset analysed in this pilot is not publicly accessible but may be made available in anonymized form upon approval by the relevant ethics committee. The copyright application for the FRIDA software (Version 0.1) has been filed and is currently under review.

Acknowledgments

The authors wish to thank all colleagues and collaborators from the Department of Neuroscience and Rehabilitation of the University of Ferrara and the Department of Mental Health and Addiction Services (DSM-DP) of the Local Health Authority (AUSL) of Ferrara for their support throughout the development and pilot study of FRIDA. During the preparation of this manuscript, the authors used ChatGPT-4 (OpenAI, 2024) to support language refinement and clarity. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AUCArea Under the Curve
BSI-18Brief Symptom Inventory-18
BSI-53Brief Symptom Inventory-53
CATComputerized Adaptive Testing
CAT-MHComputerized Adaptive Test for Mental Health
CFIComparative Fit Index
CLPConsultation Liaison Psychiatry
DCPRDiagnostic Criteria for Psychosomatic Research
DCPR/DDiagnostic Criteria for Psychosomatic Research—Demoralization module
DSM-IVDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition
DS-24Demoralization Scale, 24 items
FRIDAFour-factor Rapid Interactive Diagnostic Assessment
GRMGraded Response Model
IRTItem Response Theory
KLKullback–Leibler divergence
PHQ-9Patient Health Questionnaire-9
PROMISPatient-Reported Outcomes Measurement Information System
QMCEMQuasi Monte Carlo Expectation-Maximization
ROCReceiver Operating Characteristic
RMSEARoot Mean Square Error of Approximation
RMSDRoot Mean Square Deviation
SEStandard Error
SRMSRStandardized Root Mean Square Residual
TLITucker–Lewis Index

References

  1. Belvederi Murri, M.; Caruso, R.; Ounalli, H.; Zerbinati, L.; Berretti, E.; Costa, S.; Recla, E.; Folesani, F.; Kissane, D.; Nanni, M.G.; et al. The relationship between demoralization and depressive symptoms among patients from the general hospital: Network and exploratory graph analysis. J. Affect. Disord. 2020, 276, 137–146. [Google Scholar] [CrossRef]
  2. Grassi, L.; Belvederi Murri, M.; Riba, M.; de Padova, S.; Bertelli, T.; Sabato, S.; Nanni, M.G.; Caruso, R.; Ounalli, H.; Zerbinati, L. Hostility in cancer patients as an underexplored facet of distress. Psychooncology 2021, 30, 493–503. [Google Scholar] [CrossRef]
  3. Walker, J.; Burke, K.; Wanat, M.; Fisher, R.; Fielding, J.; Mulick, A.; Puntis, S.; Sharpe, J.; Esposti, M.D.; Harriss, E.; et al. The prevalence of depression in general hospital inpatients: A systematic review and meta-analysis of interview-based studies. Psychol. Med. 2018, 48, 2285–2298. [Google Scholar] [CrossRef] [PubMed]
  4. Walker, J.; van Niekerk, M.; Hobbs, H.; Toynbee, M.; Magill, N.; Bold, R.; Hampsey, E.; Harriss, E.; Frost, C.; Sharpe, M. The prevalence of anxiety in general hospital inpatients: A systematic review and meta-analysis. Gen. Hosp. Psychiatry 2021, 72, 131–140. [Google Scholar] [CrossRef]
  5. Croce, E.; Simonelli, G.; Ferrara, M.; Escelsior, A.; Folesani, F.; Bovio, A.; Muscettola, A.; Toffanin, T.; De Bellis, G.A.; Nanni, M.G.; et al. Correlates of Impaired Timing Abilities in Schizophrenia: A Systematic Review. J. Nerv. Ment. Dis. 2024, 212, 603–622. [Google Scholar] [CrossRef] [PubMed]
  6. Belvederi Murri, M.; Grassi, L.; Caruso, R.; Nanni, M.G.; Zerbinati, L.; Andreas, S.; Ausín, B.; Canuto, A.; Härter, M.; Lopez, M.M.; et al. Depressive symptom complexes of community-dwelling older adults: A latent network model. Mol. Psychiatry 2022, 27, 1075–1082. [Google Scholar] [CrossRef]
  7. Folesani, F.; Luviè, L.; Palazzi, C.; Marchesi, C.; Rossi, R.; Belvederi Murri, M.; Ossola, P. Psychopathology, Personality and Depression after Acute Coronary Syndrome: A Network Analysis in an Italian Population. Diagnostics 2023, 13, 915. [Google Scholar] [CrossRef]
  8. Murri, M.B.; Caruso, R.; Christensen, A.P.; Folesani, F.; Nanni, M.G.; Grassi, L. The facets of psychopathology in patients with cancer: Cross-sectional and longitudinal network analyses. J. Psychosom. Res. 2023, 165, 111139. [Google Scholar] [CrossRef]
  9. Belvederi Murri, M.; Folesani, F.; Azzolina, D.; Muscettola, A.; Bobevski, I.; Triolo, F.; Farkas, G.; Braccia, F.; Gavesi, M.; Toffanin, T.; et al. A tale of two constructs: Combined assessment of demoralization and subjective incompetence. Psychol. Health Med. 2024, 29, 1635–1651. [Google Scholar] [CrossRef]
  10. Tecuta, L.; Tomba, E.; Grandi, S.; Fava, G.A. Demoralization: A systematic review on its clinical characterization. Psychol. Med. 2015, 45, 673–691. [Google Scholar] [CrossRef]
  11. Maier, W.; Falkai, P. The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int. Clin. Psychopharmacol. 1999, 14 (Suppl. S2), S1–S6. [Google Scholar]
  12. Benarous, X.; Lahaye, H.; Consoli, A.; Cohen, D.; Labelle, R.; Guilé, J.-M. Prevalence and comorbidity rates of disruptive mood dysregulation disorder in epidemiological and clinical samples: Systematic review and meta-analysis. Eur. Psychiatry J. Assoc. Eur. Psychiatr. 2025, 68, e11. [Google Scholar] [CrossRef] [PubMed]
  13. Rizk, M.; Tebeka, S.; Dubertret, C.; Le Strat, Y. Prevalence, correlates and comorbidity of irritability in adults with major depressive episode in the U.S. population (2012–2013). J. Psychiatr. Res. 2025, 181, 517–522. [Google Scholar] [CrossRef] [PubMed]
  14. Belvederi Murri, M.; Zerbinati, L.; Ounalli, H.; Kissane, D.; Casoni, B.; Leoni, M.; Rossi, G.; Dall’Olio, R.; Caruso, R.; Nanni, M.G.; et al. Assessing demoralization in medically ill patients: Factor structure of the Italian version of the demoralization scale and development of short versions with the item response theory framework. J. Psychosom. Res. 2020, 128, 109889. [Google Scholar] [CrossRef] [PubMed]
  15. Yohannes, A.M.; Murri, M.B.; Hanania, N.A.; Regan, E.A.; Iyer, A.; Bhatt, S.P.; Kim, V.; Kinney, G.L.; Wise, R.A.; Eakin, M.N.; et al. Depressive and anxiety symptoms in patients with COPD: A network analysis. Respir. Med. 2022, 198, 106865. [Google Scholar] [CrossRef]
  16. Ghio, L.; Gotelli, S.; Cervetti, A.; Respino, M.; Natta, W.; Marcenaro, M.; Serafini, G.; Vaggi, M.; Amore, M.; Belvederi Murri, M. Duration of untreated depression influences clinical outcomes and disability. J. Affect. Disord. 2015, 175, 224–228. [Google Scholar] [CrossRef]
  17. Wood, R.; Wand, A.P.F. The effectiveness of consultation-liaison psychiatry in the general hospital setting: A systematic review. J. Psychosom. Res. 2014, 76, 175–192. [Google Scholar] [CrossRef]
  18. Mekonen, T.; Ford, S.; Chan, G.C.K.; Hides, L.; Connor, J.P.; Leung, J. What is the short-term remission rate for people with untreated depression? A systematic review and meta-analysis. J. Affect. Disord. 2022, 296, 17–25. [Google Scholar] [CrossRef]
  19. Scott, A.J.; Bisby, M.A.; Heriseanu, A.I.; Hathway, T.; Karin, E.; Gandy, M.; Dudeney, J.; Staples, L.G.; Titov, N.; Dear, B.F. Understanding the untreated course of anxiety disorders in treatment-seeking samples: A systematic review and meta-analysis. J. Anxiety Disord. 2022, 89, 102590. [Google Scholar] [CrossRef]
  20. Balestrieri, M.; Rucci, P.; Murri, M.B.; Caruso, R.; D’Agostino, A.; Ferrari, S.; Nanni, M.G.; Palagini, L.; Pini, S.; Politi, P.; et al. Suicide risk in medically ill inpatients referred to consultation-liaison psychiatric services: A multicenter study. J. Affect. Disord. 2022, 319, 329–335. [Google Scholar] [CrossRef]
  21. Zerbinati, L.; Palagini, L.; Balestrieri, M.; Belvederi Murri, M.; Caruso, R.; D’Agostino, A.; Ferrara, M.; Ferrari, S.; Minervino, A.; Milia, P.; et al. Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study. Front. Psychiatry 2022, 13, 959399. [Google Scholar] [CrossRef]
  22. Cosgrove, L.; Karter, J.M.; Vaswani, A.; Thombs, B.D. Unexamined assumptions and unintended consequences of routine screening for depression. J. Psychosom. Res. 2018, 109, 9–11. [Google Scholar] [CrossRef] [PubMed]
  23. Akhtar, H.; Vekety, B.; Kovacs, K. The Effect of Computerized Adaptive Testing on Motivation and Anxiety: A Systematic Review and Meta-Analysis. Assessment 2023, 30, 1379–1390. [Google Scholar] [CrossRef] [PubMed]
  24. Gibbons, R.D.; de Gruy, F.V. Without Wasting a Word: Extreme Improvements in Efficiency and Accuracy Using Computerized Adaptive Testing for Mental Health Disorders (CAT-MH). Curr. Psychiatry Rep. 2019, 21, 67. [Google Scholar] [CrossRef] [PubMed]
  25. Hulvershorn, L.A.; Adams, Z.W.; Smoker, M.P.; Aalsma, M.C.; Gibbons, R.D. Development of a computerized adaptive substance use disorder scale for screening, measurement and diagnosis—The CAT-SUD-E. Drug Alcohol Depend. Rep. 2022, 3, 100047. [Google Scholar] [CrossRef] [PubMed]
  26. Fischer, H.F.; Klug, C.; Roeper, K.; Blozik, E.; Edelmann, F.; Eisele, M.; Störk, S.; Wachter, R.; Scherer, M.; Rose, M.; et al. Screening for mental disorders in heart failure patients using computer-adaptive tests. Qual. Life Res. 2014, 23, 1609–1618. [Google Scholar] [CrossRef]
  27. Lentz, T.A.; Kallen, M.A.; Deutscher, D.; George, S.Z. Development of Reliable and Valid Negative Mood Screening Tools for Orthopaedic Patients with Musculoskeletal Pain. Clin. Orthop. 2022, 480, 313–324. [Google Scholar] [CrossRef]
  28. Wang, C.; Weiss, D.J.; Su, S.; Suen, K.Y.; Basford, J.; Cheville, A.L. Multidimensional Computerized Adaptive Testing: A Potential Path Toward the Efficient and Precise Assessment of Applied Cognition, Daily Activity, and Mobility for Hospitalized Patients. Arch. Phys. Med. Rehabil. 2022, 103, S3–S14. [Google Scholar] [CrossRef]
  29. Grassi, L.; Costantini, A.; Kissane, D.; Brunetti, S.; Caruso, R.; Piazza, G.; Marchetti, P.; Sabato, S.; Nanni, M.G. The factor structure and use of the Demoralization Scale (DS-IT) in Italian cancer patients. Psychooncology 2017, 26, 1965–1971. [Google Scholar] [CrossRef]
  30. Fava, G.A.; Freyberger, H.J.; Bech, P.; Christodoulou, G.; Sensky, T.; Theorell, T.; Wise, T.N. Diagnostic criteria for use in psychosomatic research. Psychother. Psychosom. 1995, 63, 1–8. [Google Scholar] [CrossRef]
  31. Mangelli, L.; Rafanelli, C.; Porcelli, P.; Fava, G.A. Appendix 2. Interview for the diagnostic criteria for psychosomatic research. Adv. Psychosom. Med. 2007, 28, 174–181. [Google Scholar] [CrossRef]
  32. Porcelli, P.; Guidi, J. The Clinical Utility of the Diagnostic Criteria for Psychosomatic Research: A Review of Studies. Psychother. Psychosom. 2015, 84, 265–272. [Google Scholar] [CrossRef] [PubMed]
  33. Porcelli, P.; Rafanelli, C. Criteria for psychosomatic research (DCPR) in the medical setting. Curr. Psychiatry Rep. 2010, 12, 246–254. [Google Scholar] [CrossRef] [PubMed]
  34. Derogatis, L.R. Symptom Checklist-90-Revised, Brief Symptom Inventory, and BSI-18. In Handbook of Psychological Assessment in Primary Care Settings; Routledge: Oxfordshire, UK, 2017; ISBN 978-1-315-65840-7. [Google Scholar]
  35. Rizzo, R.; Piccinelli, M.; Mazzi, M.; Bellantuono, C.; Tansella, M. The Personal Health Questionnaire: A new screening instrument for detection of ICD-10 depressive disorders in primary care. Psychol. Med. 2000, 30, 831–840. [Google Scholar] [CrossRef]
  36. Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001, 16, 606-613. [Google Scholar] [CrossRef]
  37. Chalmers, R.P. Mirt: A Multidimensional Item Response Theory Package for the R Environment. J. Stat. Softw. 2012, 48, 1–29. [Google Scholar] [CrossRef]
  38. Kappenburg-ten Holt, J. A Comparison Between Factor Analysis and Item Response Theory Modeling in Scale Analysis. Ph.D. Thesis, University of Groningen, Groningen, The Netherlands, 2014. Available online: https://www.rug.nl/research/portal/publications/a-comparison-between-factor-analysis-and-item-response-theory-modeling-in-scale-analysis(5a4e44c0-a8ab-4ac4-8ce2-33caa55a8fa5).html (accessed on 8 September 2025).
  39. Chalmers, R.P. Generating Adaptive and Non-Adaptive Test Interfaces for Multidimensional Item Response Theory Applications. J. Stat. Softw. 2016, 71, 1–38. [Google Scholar] [CrossRef]
  40. Junghaenel, D.U.; Schneider, S.; Stone, A.A.; Christodoulou, C.; Broderick, J.E. Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue. J. Psychosom. Res. 2014, 76, 300–306. [Google Scholar] [CrossRef]
  41. Gibbons, R.D.; Weiss, D.J.; Frank, E.; Kupfer, D. Computerized Adaptive Diagnosis and Testing of Mental Health Disorders. Annu. Rev. Clin. Psychol. 2016, 12, 83–104. [Google Scholar] [CrossRef]
  42. Bass, V.; Brown, F.; Beiser, D.G.; Peterson, T.; Gibbons, R.D.; Nagele, P. Preoperative Assessment of Anxiety and Depression Using Computerized Adaptive Screening Tools: A Pilot Prospective Cohort Study. Anesth. Analg. 2022, 134, 853–857. [Google Scholar] [CrossRef]
  43. Engel, D.; Meyer, C.; Senderling, S.; Fiore, E.; Lee, L.; Lum, J.; Hildebrand, A.; Kellogg, M.; Callahan, M. Adaptive mental health screening in veterans admitted to an epilepsy monitoring unit. Epilepsy Behav. EB 2025, 171, 110628. [Google Scholar] [CrossRef]
  44. Franco, M.I.; Staab, E.M.; Zhu, M.; Knitter, A.; Wan, W.; Gibbons, R.; Vinci, L.; Shah, S.; Yohanna, D.; Beckman, N.; et al. Pragmatic Clinical Trial of Population Health, Portal-Based Depression Screening: The PORTAL-Depression Study. J. Gen. Intern. Med. 2023, 38, 857–864. [Google Scholar] [CrossRef]
  45. Muscettola, A.; Belvederi Murri, M.; Specchia, M.; De Bellis, G.A.; Montemitro, C.; Sancassiani, F.; Perra, A.; Zaccagnino, B.; Olivetti, A.F.; Sciavicco, G.; et al. Development and Piloting of Co.Ge.: A Web-Based Digital Platform for Generative and Clinical Cognitive Assessment. J. Pers. Med. 2025, 15, 423. [Google Scholar] [CrossRef]
Figure 1. Item Characteristic Curves for all FRIDA items.
Figure 1. Item Characteristic Curves for all FRIDA items.
Jcm 14 06992 g001
Figure 2. Example of screening with the Computerized Adaptive Testing.
Figure 2. Example of screening with the Computerized Adaptive Testing.
Jcm 14 06992 g002
Figure 3. Distribution of administered items in CAT simulations (a) with virtual and real examinees (b).
Figure 3. Distribution of administered items in CAT simulations (a) with virtual and real examinees (b).
Jcm 14 06992 g003
Figure 4. User interface of the FRIDA Platform (Italian version). (a) Initial access page. (b) Results interface displaying dimensional feedback (Anxiety, Demoralization, Hostility, Depression).
Figure 4. User interface of the FRIDA Platform (Italian version). (a) Initial access page. (b) Results interface displaying dimensional feedback (Anxiety, Demoralization, Hostility, Depression).
Jcm 14 06992 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Belvederi Murri, M.; Muscettola, A.; Specchia, M.; Montemitro, C.; Zerbinati, L.; Cruciata, M.; Toffanin, T.; Sciavicco, G.; Caruso, R.; Sancassiani, F.; et al. FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients. J. Clin. Med. 2025, 14, 6992. https://doi.org/10.3390/jcm14196992

AMA Style

Belvederi Murri M, Muscettola A, Specchia M, Montemitro C, Zerbinati L, Cruciata M, Toffanin T, Sciavicco G, Caruso R, Sancassiani F, et al. FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients. Journal of Clinical Medicine. 2025; 14(19):6992. https://doi.org/10.3390/jcm14196992

Chicago/Turabian Style

Belvederi Murri, Martino, Angela Muscettola, Michele Specchia, Chiara Montemitro, Luigi Zerbinati, Marco Cruciata, Tommaso Toffanin, Guido Sciavicco, Rosangela Caruso, Federica Sancassiani, and et al. 2025. "FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients" Journal of Clinical Medicine 14, no. 19: 6992. https://doi.org/10.3390/jcm14196992

APA Style

Belvederi Murri, M., Muscettola, A., Specchia, M., Montemitro, C., Zerbinati, L., Cruciata, M., Toffanin, T., Sciavicco, G., Caruso, R., Sancassiani, F., Carta, M. G., Grassi, L., & Nanni, M. G. (2025). FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients. Journal of Clinical Medicine, 14(19), 6992. https://doi.org/10.3390/jcm14196992

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop